TY - JOUR
T1 - Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors
AU - Aggen, David H.
AU - Chervin, Adam S.
AU - Insaidoo, Francis K.
AU - Piepenbrink, Kurt H.
AU - Baker, Brian M.
AU - Kranz, David M.
N1 - Funding Information:
This work was supported by the National Institutes of Health (R01 GM55767 and P01 CA097296 to D.M.K., R01 GM067079 to B.M.B.) and a grant from the McDonnell Foundation (to D.M.K.). K.H.P. and F.K.I. were supported by the Notre Dame CBBI training program, funded by NIH grant T32 GM075762.
PY - 2011/4
Y1 - 2011/4
N2 - Single-chain antibody fragments (scFv), consisting of two linked variable regions (VH and VL), are a versatile format for engineering and as potential antigen-specific therapeutics. Although the analogous format for T cell receptors (TCRs), consisting of two linked V regions (V and V; referred to here as scTv), could provide similar opportunities, all wild-type scTv proteins examined to date are unstable. This obstacle has prevented scTv fragments from being widely used for engineering or therapeutics. To further explore whether some stable human scTv fragments could be expressed, we used a yeast system in which display of properly folded domains correlates with ability to express the folded scTv in soluble form. We discovered that, unexpectedly, scTv fragments that contained the human V2 region (IMGT: TRAV12 family) were displayed and properly associated with different V regions. Furthermore, a single polymorphic residue (Ser49) in the framework region conferred additional thermal stability. These stabilized V2-containing scTv fragments could be expressed at high levels in Escherichia coli, and used to stain target cells that expressed the specific pep-HLA-A2 complexes. Thus, the scTv fragments can serve as a platform for engineering TCRs with diverse specificities, and possibly for therapeutic or diagnostic applications.
AB - Single-chain antibody fragments (scFv), consisting of two linked variable regions (VH and VL), are a versatile format for engineering and as potential antigen-specific therapeutics. Although the analogous format for T cell receptors (TCRs), consisting of two linked V regions (V and V; referred to here as scTv), could provide similar opportunities, all wild-type scTv proteins examined to date are unstable. This obstacle has prevented scTv fragments from being widely used for engineering or therapeutics. To further explore whether some stable human scTv fragments could be expressed, we used a yeast system in which display of properly folded domains correlates with ability to express the folded scTv in soluble form. We discovered that, unexpectedly, scTv fragments that contained the human V2 region (IMGT: TRAV12 family) were displayed and properly associated with different V regions. Furthermore, a single polymorphic residue (Ser49) in the framework region conferred additional thermal stability. These stabilized V2-containing scTv fragments could be expressed at high levels in Escherichia coli, and used to stain target cells that expressed the specific pep-HLA-A2 complexes. Thus, the scTv fragments can serve as a platform for engineering TCRs with diverse specificities, and possibly for therapeutic or diagnostic applications.
KW - T cell receptors
KW - directed evolution
KW - peptide-MHC
KW - single-chain
KW - yeast display
UR - http://www.scopus.com/inward/record.url?scp=79952654605&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952654605&partnerID=8YFLogxK
U2 - 10.1093/protein/gzq113
DO - 10.1093/protein/gzq113
M3 - Article
C2 - 21159619
AN - SCOPUS:79952654605
SN - 1741-0126
VL - 24
SP - 361
EP - 372
JO - Protein Engineering, Design and Selection
JF - Protein Engineering, Design and Selection
IS - 4
ER -